Geneos Wealth Management’s Robert Half RHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-22
Closed -$903 3034
2025
Q2
$903 Sell
22
-86
-80% -$3.92K ﹤0.01% 3015
2025
Q1
$7.64K Buy
108
+88
+440% +$5.37K ﹤0.01% 2649
2024
Q4
$1.41K Hold
20
﹤0.01% 2687
2024
Q3
$1.35K Buy
+20
New +$1.27K ﹤0.01% 2385
2021
Q2
Sell
-175
Closed -$15K 3062
2021
Q1
$15K Buy
+175
New +$12.7K ﹤0.01% 2213
2020
Q4
Sell
-100
Closed -$5K 2983
2020
Q3
$5K Hold
100
﹤0.01% 2196
2020
Q2
$5K Hold
100
﹤0.01% 2162
2020
Q1
$3K Sell
100
-143
-59% -$7.74K ﹤0.01% 2200
2019
Q4
$15K Hold
243
﹤0.01% 1810
2019
Q3
$13K Hold
243
﹤0.01% 1788
2019
Q2
$13K Buy
243
+98
+68% +$5.85K ﹤0.01% 1819
2019
Q1
$9K Sell
145
-32
-18% -$2.03K ﹤0.01% 1874
2018
Q4
$9K Hold
177
﹤0.01% 1826
2018
Q3
$12K Buy
+177
New +$13K ﹤0.01% 1788

Other funds holding RHI

Geneos Wealth Management's RHI Position: Q3 2025 in Review

Geneos Wealth Management sold out of Robert Half (RHI) in Q3 2025, closing a stake of 22 shares — an estimated $903 sold.

Geneos Wealth Management first reported a position in RHI in Q3 2018 and held it in 14 quarters. The position peaked at $15K in Q1 2021. 440 funds tracked by Wall St. Rank hold RHI as of Q3 2025.

  • Geneos Wealth Management reported no remaining Robert Half position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 22 Robert Half shares in Q3 2025, an estimated $903.
  • Geneos Wealth Management first reported a position in Robert Half in Q3 2018 and held it in 14 quarters.
  • Geneos Wealth Management's Robert Half position peaked at $15K in Q1 2021.
  • 440 funds tracked by Wall St. Rank held Robert Half as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.